Darunavir Ethanolate

CAS : 635728-49-3

Ref. 3D-FD64995

Informations sur le produit

• Nom: Darunavir Ethanolate
• Marque: Biosynth
• Description: Darunavir is a HIV-1 protease inhibitor used orally in the treatment of patients with multi-drug resistant HIV-1 infection (Ghosh, 2007). It has also been shown to be effective against other infectious diseases such as hepatitis C virus and SARS coronavirus. Metabolized by cytochrome P450 3A (CYP3A) isoenzymes, darunavir is often administered together with ritonavir that prolongs its bioavaiability, giving a terminal elimination half-life (t1/2) of 15 hours (Back, 2008). The effect of darunavir on natural compounds such as matrix proteins and toll-like receptor activity has also been studied via high performance liquid chromatography (HPLC) experiments.

Propriétés chimiques

• Masse moléculaire: 593.73 g/mol
• Formule: C₂₇H₃₇N₃O₇S·C₂H₆O
• Degré de pureté: Min. 95%
• Couleur/Forme: White Powder